click on circles to display study description...
everolimus (n=-9) vs. placebo (n=-9)
randomized controlled trial
everolimus for 2 years combined with standard endocrine therapy
placebo for 2 years combined with standard placebo
breast cancer - adjuvant
double-blind
powered by vis.js Network